2023
DOI: 10.1016/j.phro.2023.100515
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Implementation and Evaluation of Auto-Segmentation Tools for Multi-Site Contouring in Radiotherapy

Gerd Heilemann,
Martin Buschmann,
Wolfgang Lechner
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 28 publications
(50 reference statements)
0
2
0
Order By: Relevance
“…The oncologist noted that PCMs are generally thin (3 mm), but slight widening was observed on number of presented examples. We explored the relationship between DSC metrics and clinical acceptability criteria, building on Heilemann et al.’s ( 44 ) suggestion of a DSC threshold above 0.7 for clinical acceptability. However, due to size-dependent characteristics, smaller ROIs may still be deemed acceptable with DSC below 0.7.…”
Section: Discussionmentioning
confidence: 99%
“…The oncologist noted that PCMs are generally thin (3 mm), but slight widening was observed on number of presented examples. We explored the relationship between DSC metrics and clinical acceptability criteria, building on Heilemann et al.’s ( 44 ) suggestion of a DSC threshold above 0.7 for clinical acceptability. However, due to size-dependent characteristics, smaller ROIs may still be deemed acceptable with DSC below 0.7.…”
Section: Discussionmentioning
confidence: 99%
“…Medical software must be evaluated by the Food and Drug Administration (FDA) before entering the US market, an untenably slow process prior to the FDA’s amended regulatory protocol in 2019 ( 24 ), and the cost of these systems may also be prohibitive for some less-resourced clinics. Additionally, commercial providers for radiation oncology have been slow to focus efforts on incorporating AI into clinical workflows and their limited access to clinical datasets makes it challenging for them to meet high quality standards ( 2 , 25 ). Consequently, academic centers are largely left to develop their own home-grown solutions.…”
Section: Introductionmentioning
confidence: 99%